Literature DB >> 34216204

Risk of Transmission and Viral Shedding From the Time of Infection for Respiratory Syncytial Virus in Households.

Hirono Otomaru, Johanna Beulah T Sornillo, Taro Kamigaki, Samantha Louise P Bado, Michiko Okamoto, Mariko Saito-Obata, Marianette T Inobaya, Edelwisa Segubre-Mercado, Portia P Alday, Mayuko Saito, Veronica L Tallo, Beatriz P Quiambao, Hitoshi Oshitani, Alex R Cook.   

Abstract

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection worldwide, but reports of temporal changes in the risk of transmission among close contacts has been scarce. This study aimed to examine an association between the viral load trajectory and transmission risk to develop a better control strategy for the disease spread. We conducted a household-based prospective cohort study in Biliran Province, the Philippines, and enrolled 451 participants to observe the development of acute respiratory infection. Including the cases found at the health-care facility, we analyzed the data of viral loads with symptom records obtained from 172 followed participants who had household member positive for RSV with a rapid test during an RSV outbreak in 2018-2019. We developed a model estimating a temporal change in the viral shedding from the infection and evaluated transmission dynamics. We found that most transmission events occurred within approximately 7 days of the household exposure, including potential presymptomatic transmissions. The inferred risk of infection among those younger than 5 years was 3.5 times higher than that of those older than 5 years. This finding suggested that the initial week after the household exposure is particularly important for preventing RSV spread.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.

Entities:  

Keywords:  infectious disease transmission; mathematical model; respiratory syncytial virus; viral load

Mesh:

Year:  2021        PMID: 34216204      PMCID: PMC8634588          DOI: 10.1093/aje/kwab181

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  35 in total

1.  Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children.

Authors:  Chadi M El Saleeby; Andy J Bush; Lisa M Harrison; Jody A Aitken; John P Devincenzo
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

Review 2.  Immunology of viral respiratory tract infection in infancy.

Authors:  James E Crowe; John V Williams
Journal:  Paediatr Respir Rev       Date:  2003-06       Impact factor: 2.726

Review 3.  A multifaceted approach to RSV vaccination.

Authors:  Jorge C G Blanco; Marina S Boukhvalova; Trudy G Morrison; Stefanie N Vogel
Journal:  Hum Vaccin Immunother       Date:  2018-06-19       Impact factor: 3.452

4.  Incidence and Risk Factors of Childhood Pneumonia-Like Episodes in Biliran Island, Philippines--A Community-Based Study.

Authors:  Hisato Kosai; Raita Tamaki; Mayuko Saito; Kentaro Tohma; Portia Parian Alday; Alvin Gue Tan; Marianette Tawat Inobaya; Akira Suzuki; Taro Kamigaki; Soccoro Lupisan; Veronica Tallo; Hitoshi Oshitani
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 5.  The CD8 T Cell Response to Respiratory Virus Infections.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 6.  Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.

Authors:  Seyhan Boyoglu-Barnum; Tatiana Chirkova; Larry J Anderson
Journal:  Front Immunol       Date:  2019-07-25       Impact factor: 7.561

Review 7.  Strategic priorities for respiratory syncytial virus (RSV) vaccine development.

Authors:  L J Anderson; P R Dormitzer; D J Nokes; R Rappuoli; A Roca; B S Graham
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

8.  The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants.

Authors:  Charles J Sande; Patricia A Cane; D J Nokes
Journal:  Vaccine       Date:  2014-07-06       Impact factor: 3.641

9.  Association Between Preceding Viral Respiratory Infection and Subsequent Respiratory Illnesses Among Children: A Prospective Cohort Study in the Philippines.

Authors:  Yuki Furuse; Raita Tamaki; Michiko Okamoto; Mariko Saito-Obata; Akira Suzuki; Mayuko Saito; Tadatsugu Imamura; Irona Khandaker; Isolde Dapat; Fumihiko Ueno; Portia Parian Alday; Alvin Gue Tan; Marianette Tawat Inobaya; Edelwisa Segubre-Mercado; Veronica Tallo; Socorro Lupisan; Hitoshi Oshitani
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

10.  A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.

Authors:  Roy F Chemaly; Sanjeet S Dadwal; Anne Bergeron; Per Ljungman; Yae-Jean Kim; Guang-Shing Cheng; Sudhakar N Pipavath; Ajit P Limaye; Elodie Blanchard; Drew J Winston; Patrick J Stiff; Tsila Zuckerman; Silvy Lachance; Galia Rahav; Catherine B Small; Kathleen M Mullane; Roberto L Patron; Dong-Gun Lee; Hans H Hirsch; Alpana Waghmare; Matt McKevitt; Robert Jordan; Ying Guo; Polina German; Danielle P Porter; David L Gossage; Timothy R Watkins; Francisco M Marty; Jason W Chien; Michael Boeckh
Journal:  Clin Infect Dis       Date:  2020-12-31       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.